Ind-Swift Laboratories

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue246.64306.65280.17310.21312.69
Expenses215.51351.76243.44267.86274.31
EBITDA31.13-45.1136.7342.3538.38
EBIT9.87-126.9220.4525.9422.99
Profit Before Tax15.81-47.4020.1425.9124.35
Net Profit16.03-61.4519.8825.3427.50
Financial Ratios
Operating Profit Margin12.62%-14.71%13.11%13.65%12.27%
Net Profit Margin6.50%-20.04%7.10%8.17%8.79%
Earning Per Share (Diluted)2.71-10.393.364.294.65
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.8.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI